Literature DB >> 8893637

Hypertrophic osteoarthropathy in staging skeletal scintigraphy for lung cancer.

B Morgan1, F Coakley, D B Finlay, I Belton.   

Abstract

AIM: To assess the prognostic significance of hypertropic osteoarthropathy (HOA) discovered on routine staging bone scintigraphy in patients with lung cancer. PATIENTS AND METHODS: Between 1989 and 1992 all 99mTc-MDP bone scintigrams performed for the staging of bronchogenic carcinoma were reviewed. HOA was diagnosed by the observation of cortical/periosteal increased uptake in the extremities of the long bones. Follow-up and confirmation of the diagnosis was obtained by hospital computer, histology records, operative records, patient notes and radiological data where available.
RESULTS: 164 staging scintigrams for lung cancer were identified. Twenty-eight patients (17%) were observed to have HOA. Patients with and without HOA were well matched for age and sex. There was little difference in the distribution of cell type but the HOA groups has a greater incidence of peripheral tumours. There was no significance in survival between the two groups. Two of three long-term survivors had clinically overt HOA and one presented with arthralgia.
CONCLUSION: HOA is often seen on skeletal scintigraphy for staging of lung cancer and has no prognostic significance. The data also support current teaching that a high index of suspicion for HOA, as a cause of arthralgia may lead to early diagnosis of a potentially resectable lung carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893637     DOI: 10.1016/s0009-9260(96)80240-6

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  6 in total

1.  Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

Authors:  N Campanella; A Moraca; M Pergolini; W Daher; A Fianchini; A Sabbatini; A Brunelli; M Al-Refai
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Hypertrophic pulmonary osteoarthropathy on bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in a patient with lung adenocarcinoma.

Authors:  Arzu Cengiz; Mine Şencan Eren; Mehmet Polatli; Yakup Yürekli
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

3.  Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer.

Authors:  Yu-Hung Fang; Chien-Chin Hsu; Meng-Jer Hsieh; Ming-Szu Hung; Ying-Huang Tsai; Yu-Ching Lin
Journal:  Onco Targets Ther       Date:  2017-10-25       Impact factor: 4.147

Review 4.  Management of paraneoplastic syndromes in lung cancer.

Authors:  Leno Thomas; Young Kwok; Martin J Edelman
Journal:  Curr Treat Options Oncol       Date:  2004-02

5.  Hypertrophic osteoarthropathy as the cause of a super scan of the bone in a patient with prostate cancer: a case report.

Authors:  Boris L J Kanen; Ruud J L F Loffeld
Journal:  J Med Case Rep       Date:  2008-04-07

6.  Hypertrophic pulmonary osteoarthropathy with primary lung cancer.

Authors:  Xinyu Qian; Jing Qin
Journal:  Oncol Lett       Date:  2014-04-02       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.